News Quantified

Stock Stats

News Stats


All News	{{AllNewsCount}}
News Wires	{{NewsWiresCount}}
Media Monitoring	{{MoreOverCount}}
SEC Edgar Filings	{{SecEdgarFilingsCount}}
Upgrades	{{UpgradesCount}}
Downgrades	{{DowngradesCount}}
Initiated	{{InitiatesCount}}
Reiterated	{{ReiteratesCount}}
Last Earnings	{{LastEarnings}}
Last Earnings EPS	{{LastEps}}
Next Earnings	{{NextEarnings}}

Order Stats

Sub-Penny
{{SubPennyStr}}
Odd Lot
{{OddLotStr}}
Avg. bid-ask spread

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

Ceribell to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

CeriBell (NASDAQ: CBLL) had its price target raised by analysts at TD Cowen from $31.00 to $36.00. They now have a "buy" rating on the stock.

CeriBell (NASDAQ: CBLL) had its price target raised by analysts at Canaccord Genuity Group Inc. from $31.00 to $33.00. They now have a "buy" rating on the stock.

CeriBell (NASDAQ: CBLL) had its price target raised by analysts at Canaccord Genuity Group Inc. from $30.00 to $31.00. They now have a "buy" rating on the stock.

Ceribell Reports Third Quarter 2024 Financial Results

11/12/2024

04:05 pm

CBLL

-3.4%

MISS

Form 4 Ceribell, Inc. For: Dec 23 Filed by: Blumberg Scott

Form 10-Q Ceribell, Inc. For: Sep 30

Form 8-K Ceribell, Inc. For: Nov 12

Form SEC STAFF LETTER Ceribell, Inc.

Form SEC STAFF LETTER Ceribell, Inc.

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}